Biobank DNA leftovers unlock secrets of Epstein–Barr virus
TL;DR Summary
Researchers show that non-human DNA discarded during whole-genome sequencing can be repurposed to detect and quantify Epstein–Barr virus DNA in human cells, using a method described by Nyeo et al. in Nature. This population-scale approach lets biobanks reveal persistent EBV DNA and its links to complex diseases, turning sequencing byproducts into a new source of epidemiological insight.
- Scraps of viral DNA in biobank samples reveal secrets of Epstein–Barr virus Nature
- Population-scale sequencing resolves determinants of persistent EBV DNA Nature
- This virus infects most of us – but why do only some get very ill? New Scientist
- Genomics Unlocks How DNA and Viruses Come Together To Shape Chronic Disease Memorial Sloan Kettering Cancer Center
- Scientists Inch Closer to Solving the ‘Kissing Disease’ Mystery Bloomberg.com
Reading Insights
Total Reads
1
Unique Readers
14
Time Saved
11 min
vs 12 min read
Condensed
98%
2,344 → 57 words
Want the full story? Read the original article
Read on Nature